ARCHIVES

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

This article is from The Cancer Letter archive.

Vol. 25 No. 09 | March 5, 1999

Download PDF Visit The Full Archive

Related Articles

Reports: Tobacco Cessation Underused, NIH Panel Says.

June 16, 2006

Clearinghouse Finds Seven Compounds Are Carcinogenic, Human Threat

September 1, 1978

Centers Eligible For Comprehensive Identification Names; Rauscher To Pick Four Now, Two More Later

May 24, 1974

Combine Phase 1-2, Abolish DRG, Slash Indirect Costs, Garb Tells Congress

November 27, 1981

Senate Appropriators Reject President’s $228 Million Increase For Cancer Research; House and Senate Report Language

September 18, 2009

Capitol Hill: With money tight, support for 2015 goal is symbolic.

October 14, 2005